Similar articles

• Impaired capacity for endogenous fibrinolysis in essential hypertension.

  Hrafnkelsdóttir T, Wall U, Jern C, Jern S. Hrafnkelsdóttir T, et al. Lancet. 1998 Nov 14;352(9140):1597-8. doi: 10.1016/S0140-6736(05)61044-6. Lancet. 1998. PMID: 9843110 No abstract available.
• What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?

  Tay KH, Lip GY. Tay KH, et al. Am J Hypertens. 2008 Dec;21(12):1278-9. doi: 10.1038/ajh.2008.315. Am J Hypertens. 2008. PMID: 19020509 No abstract available.
• Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.

  Pärsson H, Holmberg A, Siegbahn A, Bergqvist D. Pärsson H, et al. Eur J Vasc Endovasc Surg. 2004 Feb;27(2):186-92. doi: 10.1016/j.ejvs.2003.10.015. Eur J Vasc Endovasc Surg. 2004. PMID: 14718902
• [The influence of nitric oxide on the regulation of plasminogen activator inhibitor type 1 and tissue-type plasminogen activator expression].

  Oszajca K, Szemraj J, Bartkowiak J. Oszajca K, et al. Postepy Biochem. 2005;51(4):407-13. Postepy Biochem. 2005. PMID: 16676575 Review. Polish.
• [Endothelial dysfunction and nitrogen monoxide (NO; nitric oxide)].

  Lüscher TF, Tschudi MR, Wenzel RR, Noll G. Lüscher TF, et al. Internist (Berl). 1997 May;38(5):411-9. doi: 10.1007/s001080050052. Internist (Berl). 1997. PMID: 9264977 Review. German. No abstract available.